Ukrain therapy of recurrent breast cancer with lung metastases (case report).
A recurrent breast cancer with lung metastases was treated with the new anticancer drug Ukrain. The first two courses led to subjective improvement of the general condition as well as work capability; appetite improved and shortness of breath disappeared. After the sixth course of Ukrain therapy objective improvement was found clinically on X-ray, in haematological and biochemical data and improved tumour markers. Lymph nodes and lung metastases disappeared. The patient showed a full clinical remission.
Kadan
P
P
Ukrainian Anti-Cancer Institute, Vienna, Austria.
Korsh
O B
OB
Melnyk
A
A
D000328:Adult; D000470:Alkaloids / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001600:Berberine Alkaloids; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010617:Phenanthridines
D000470:Alkaloids; D000970:Antineoplastic Agents; D001600:Berberine Alkaloids; D010617:Phenanthridines; C060921:ukrain